Cervix Neoplasms Clinical Trial
Official title:
Healing Touch in Advanced Cervical Cancer Patients: Immune Effects and Mechanisms
The purpose of this study is to evaluate the effects of healing touch and relaxation therapy on cervical cancer patients undergoing chemotherapy and radiation treatment.
The side effects of chemotherapy and radiation treatment are often severe and can have
devastating effects on the mental and physical well-being of cancer patients. This study
will determine whether healing touch and relaxation therapy are effective in minimizing the
side effects of chemotherapy and radiation treatment in cervical cancer patients.
Participants in this study will receive weekly chemotherapy and daily radiation treatments
for 6 weeks. Participants will be randomly assigned to receive either standard care (SC), SC
plus relaxation therapy, or SC plus healing touch therapy. The relaxation therapy consists
of progressive muscle relaxation and guided imagery. The healing touch therapy involves an
energy-based modality in which health care practitioners stimulate the energy fields
surrounding the patient. A physician-completed assessment and measures of immune function
will be used to assess the well-being and overall quality of life of participants.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00069160 -
Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT00039884 -
Will Radiation/Chemotherapy Treatment of Cervical Cancer Work Better With Medication That May Improve Anemia?
|
Phase 2 | |
| Completed |
NCT00127465 -
Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants
|
Phase 1/Phase 2 | |
| Completed |
NCT02184975 -
Cold Knife Conization With and Without Lateral Hemostatic Sutures
|
Phase 2 | |
| Completed |
NCT00112307 -
Magnetic Resonance Imaging Guided Gynecologic Brachytherapy
|
N/A | |
| Recruiting |
NCT04295109 -
Comparison of the Effects of Fentanyl, Oxycodone, Butorphanol on Gastrointestinal Function
|
N/A | |
| Completed |
NCT00188578 -
Intensity Modulated Radiation Therapy - Gyne Cancer (GY03.2)
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT00178802 -
Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian Cancers
|
Phase 2 | |
| Active, not recruiting |
NCT00119509 -
The IMAP Study Improving Management of Mildly Abnormal Pap Smears
|
Phase 3 | |
| Completed |
NCT00288821 -
Diagnostic Imaging of Lymph Nodes in Gynaecologic Oncology
|
N/A | |
| Completed |
NCT00152828 -
Celebrex - Cervix: Celecoxib in the Treatment of Patients With Locally Advanced Carcinoma of the Cervix
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT00188539 -
Cervix:Hypoxia, Interstitial Fluid Pressure and GSH Levels
|
Phase 2 | |
| Completed |
NCT00188695 -
Combidex USPIO - Ultra-small Superparamagnetic Iron Oxide
|
Phase 1/Phase 2 |